Literature DB >> 24343580

Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV Medicine Association of the Infectious Diseases Society of America.

Judith A Aberg1, Joel E Gallant, Khalil G Ghanem, Patricia Emmanuel, Barry S Zingman, Michael A Horberg.   

Abstract

Evidence-based guidelines for the management of persons infected with human immunodeficiency virus (HIV) were prepared by an expert panel of the HIV Medicine Association of the Infectious Diseases Society of America. These updated guidelines replace those published in 2009. The guidelines are intended for use by healthcare providers who care for HIV-infected patients. Since 2009, new antiretroviral drugs and classes have become available, and the prognosis of persons with HIV infection continues to improve. However, with fewer complications and increased survival, HIV-infected persons are increasingly developing common health problems that also affect the general population. Some of these conditions may be related to HIV infection itself or its treatment. HIV-infected persons should be managed and monitored for all relevant age- and sex-specific health problems. New information based on publications from the period 2009-2013 has been incorporated into this document.

Entities:  

Keywords:  HIV; HIV metabolic; HIV monitoring; HIV vaccines; guidelines; primary care; sexually transmitted diseases

Mesh:

Substances:

Year:  2014        PMID: 24343580     DOI: 10.1093/cid/cit757

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  89 in total

Review 1.  CROI 2016: Viral Hepatitis and Liver Fibrosis.

Authors:  Anne F Luetkemeyer; David L Wyles
Journal:  Top Antivir Med       Date:  2016 May-Jun

Review 2.  Advance Care Planning and HIV Infection in the Era of Antiretroviral Therapy: A Review.

Authors:  Aroonsiri Sangarlangkarn; Jessica S Merlin; Rodney O Tucker; Amy S Kelley
Journal:  Top Antivir Med       Date:  2016 Dec-2017 Jan

3.  Retinal nerve fiber layer changes based on historic CD4 nadir among HIV positive patients undergoing glaucoma evaluation.

Authors:  Sarah H Van Tassel; Paul Petrakos; Elizabeth Marlow; Elizabeth Mauer; Harjot K Singh; Anna M Demetriades
Journal:  Int J Ophthalmol       Date:  2019-05-18       Impact factor: 1.779

Review 4.  Endocrinological aspects of HIV infection.

Authors:  F S Mirza; P Luthra; L Chirch
Journal:  J Endocrinol Invest       Date:  2018-01-08       Impact factor: 4.256

Review 5.  Multidisciplinary Approach to the Management and Treatment of Anal Dysplasia.

Authors:  Jeffrey Douaiher; Sean J Langenfeld
Journal:  Clin Colon Rectal Surg       Date:  2018-11-02

6.  Shared decision-making around anal cancer screening among black bisexual and gay men in the USA.

Authors:  Mary Ellen Acree; Moira McNulty; Olivia Blocker; John Schneider; H 'Herukhuti' Sharif Williams
Journal:  Cult Health Sex       Date:  2019-04-01

Review 7.  Cancer disparities in people with HIV: A systematic review of screening for non-AIDS-defining malignancies.

Authors:  Kelsey L Corrigan; Kevin C Wall; John A Bartlett; Gita Suneja
Journal:  Cancer       Date:  2019-01-15       Impact factor: 6.860

8.  HCV Screening and Treatment Uptake Among Patients in HIV Care During 2014-2015.

Authors:  Daniel Radwan; Edward Cachay; Oluwaseun Falade-Nwulia; Richard D Moore; Ryan Westergaard; William Christopher Mathews; Judith Aberg; Laura Cheever; Kelly A Gebo
Journal:  J Acquir Immune Defic Syndr       Date:  2019-04-15       Impact factor: 3.731

9.  Retention, Antiretroviral Therapy Use and Viral Suppression by History of Injection Drug Use Among HIV-Infected Patients in an Urban HIV Clinical Cohort.

Authors:  Catherine R Lesko; Weiqun Tong; Richard D Moore; Bryan Lau
Journal:  AIDS Behav       Date:  2017-04

10.  Vitamin D levels and influenza vaccine immunogenicity among HIV-infected and HIV-uninfected adults.

Authors:  Nancy F Crum-Cianflone; Seunghyun Won; Rachel Lee; Tahaniyat Lalani; Anuradha Ganesan; Timothy Burgess; Brian K Agan
Journal:  Vaccine       Date:  2016-08-28       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.